PLRX logo

Pliant Therapeutics (PLRX)

Profile

Full Name

Pliant Therapeutics, Inc.

Ticker Symbol

PLRX

Exchange

NASDAQ

Country

United States

IPO

June 3, 2020

Indexes

Not included

Employees

171

Key Details

Price

$1.46(+1.39%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3.47(-26.18% YoY)

PE ratio

-

Next earnings date

May 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 18, 25 HC Wainwright & Co.
Neutral
Mar 4, 25 Wells Fargo
Equal-Weight
Mar 4, 25 RBC Capital
Sector Perform
Mar 4, 25 Needham
Hold
Mar 4, 25 HC Wainwright & Co.
Neutral
Mar 4, 25 Citigroup
Neutral
Mar 3, 25 Leerink Partners
Market Perform
Feb 14, 25 Needham
Buy
Feb 14, 25 HC Wainwright & Co.
Neutral
Feb 10, 25 Wells Fargo
Equal-Weight

Institutional Ownership

  • What is the ticker symbol for Pliant Therapeutics?
  • Does Pliant Therapeutics pay dividends?
  • What sector is Pliant Therapeutics in?
  • What industry is Pliant Therapeutics in?
  • What country is Pliant Therapeutics based in?
  • When did Pliant Therapeutics go public?
  • Is Pliant Therapeutics in the S&P 500?
  • Is Pliant Therapeutics in the NASDAQ 100?
  • Is Pliant Therapeutics in the Dow Jones?
  • When was Pliant Therapeutics's last earnings report?
  • When does Pliant Therapeutics report earnings?
  • Should I buy Pliant Therapeutics stock now?

What is the ticker symbol for Pliant Therapeutics?

The ticker symbol for Pliant Therapeutics is NASDAQ:PLRX

Does Pliant Therapeutics pay dividends?

No, Pliant Therapeutics does not pay dividends

What sector is Pliant Therapeutics in?

Pliant Therapeutics is in the Healthcare sector

What industry is Pliant Therapeutics in?

Pliant Therapeutics is in the Biotechnology industry

What country is Pliant Therapeutics based in?

Pliant Therapeutics is headquartered in United States

When did Pliant Therapeutics go public?

Pliant Therapeutics's initial public offering (IPO) was on June 3, 2020

Is Pliant Therapeutics in the S&P 500?

No, Pliant Therapeutics is not included in the S&P 500 index

Is Pliant Therapeutics in the NASDAQ 100?

No, Pliant Therapeutics is not included in the NASDAQ 100 index

Is Pliant Therapeutics in the Dow Jones?

No, Pliant Therapeutics is not included in the Dow Jones index

When was Pliant Therapeutics's last earnings report?

Pliant Therapeutics's most recent earnings report was on Mar 3, 2025

When does Pliant Therapeutics report earnings?

The next expected earnings date for Pliant Therapeutics is May 6, 2025

Should I buy Pliant Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page